Shares of Cellceutix Corp. (OTC: CTIX), a development stage biopharmaceutical company focused on the discovery and development of small molecule drugs to treat diseases mainly in the areas of cancer and inflammatory disease, rallied in trading today.
CTIX shares ended the day 18.09% higher at $2.22 on above average volume of 1.67 million. The stock hit an all-time high of $2.29 in trading today. CTIX shares have gained 40.51% in the last three trading sessions.
CTIX shares rallied in trading today after the company commented on a front page New York Times article published on December 23, 2012. The article, Genetic Gamble; New Approaches to Fighting Cancer, was written by Gina Kolata. The article discusses a seismic change in the direction that cancer research may undergo.
Leo Elrich, CEO of Cellceutix, said that he is pleased to see such a high profile article being written on the game changing impact that a p53 drug can have on treating cancers.
Shares of Amarantus BioSciences Inc. (OTC: AMBS), a development stage biotechnology company, surged in trading today.
AMBS shares ended the day 19.87% higher at $0.0760 on volume of 15.02 million. The stock hit an intra-day high of $0.08 in trading today. AMBS shares have gained 33.33% in the last three trading sessions.
AMBS shares have been soaring after the company last week announced that it will present Parkinson’s disease neurorestoration animal data results at the OneMedForum SF 2013 conference on Tuesday, January 8, 2013.
Shares of World Moto Inc. (OTC: FARE), a manufacturer and supplier of taxi meters for the motorcycle taxi industry, soared in trading today.
FARE shares ended the day 19.56% higher at $0.129 on volume of 5.95 million. The stock hit an intra-day high of $0.13 in trading today.
FARE shares rallied in trading today after the company announced that it selected SVI as its manufacturing partner for the Moto-Meter.
Recent Comments